Evermil contains everolimus, a targeted therapy that belongs to a group of drugs known as mTOR inhibitors. It is used to treat various types of cancer as well as certain non-cancerous conditions involving abnormal cell growth. Evermil helps to slow down or stop the growth of abnormal cells, especially in cases where other treatments have not been effective. It is taken orally and is often part of long-term treatment plans.

Mechanism of Action:
Everolimus works by blocking a protein in the body called mTOR, which stands for mammalian target of rapamycin. This protein plays a key role in regulating cell growth, division, and survival. In many cancers and overgrowth conditions, mTOR is overly active, leading to uncontrolled cell multiplication. By inhibiting mTOR, Evermil slows down cell growth and helps reduce the supply of nutrients and blood vessels that tumors need to grow.

Adverse Effects:
Evermil can cause side effects, especially because it affects both cancer cells and normal immune functions. Common side effects include:

• Mouth ulcers or sores

• Tiredness and weakness

• Loss of appetite or weight loss

• Increased risk of infections due to immune suppression

• Skin rash, dry skin, or acne

• Changes in blood tests, such as increased cholesterol or blood sugar